基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 抑制剂 血管生成(Angiogenesis) FLT3 抑制剂 [4-[2-(1H-吲唑-3-基)乙烯基]苯基]-1-哌嗪基甲酮 [4-[2-(1H-吲唑-3-基)乙烯基]苯基]-1-哌嗪基甲酮
  • [4-[2-(1H-吲唑-3-基)乙烯基]苯基]-1-哌嗪基甲酮-abs813234
  • [4-[2-(1H-吲唑-3-基)乙烯基]苯基]-1-哌嗪基甲酮-abs813234

1/2

[4-[2-(1H-吲唑-3-基)乙烯基]苯基]-1-哌嗪基甲酮-abs813234

现货
KW-2449
¥555 5mg 起订
¥713 10mg 起订
¥2852 50mg 起订
¥5543 100mg 起订
上海 更新日期:2026-11-17

爱必信(上海)生物科技有限公司

VIP7年

科技型中小企业

高新技术企业

联系人:爱必信
手机:13761418683 拨打
邮箱:fengmj@univ-bio.com

产品详情:

中文名称:
[4-[2-(1H-吲唑-3-基)乙烯基]苯基]-1-哌嗪基甲酮
英文名称:
KW-2449
CAS号:
1000669-72-6
品牌:
Absin
纯度规格:
<p>>98%</p>
产品类别:
其它
货号:
abs813234
一、产品概述

[4-[2-(1H-吲唑-3-基)乙烯基]苯基]-1-哌嗪基甲酮 是来自Absin品牌的高品质产品,适用于科研实验领域。

更多产品描述请查看优宁维旗下爱必信官网(https://www.absin.cn/kw-2449/abs813234.html?mk_channel=chemicalbook)

二、产品信息
货号abs813234
SKU货号abs813234-10mg
品牌Absin
中文名称[4-[2-(1H-吲唑-3-基)乙烯基]苯基]-1-哌嗪基甲酮
英文名称KW-2449
CAS号1000669-72-6
纯度

>98%

分子量332.40
可溶性DMSO : ≥ 50 mg/mL (150.42 mM)
抗原名称FLT3 (D835Y) ,Abl (T315I) ,FLT3 ,Abl ,FGFR1
商品描述

KW-2449是一种多靶点抑制剂,最有效作用于Flt3,IC50为6.6 nM,作用于Flt3, Bcr-Abl和Aurora A适度有效;对PDGFRβ, IGF-1R, EGFR没有抑制效果。KW-2449是FLT3, ABL, ABL-T315I, 和Aurora激酶的多激酶抑制剂,用于治疗白血病患者。KW-2449作用于携带FLT3突变的白血病细胞,通过抑制FLT3激酶,而有效抑制生长,导致磷酸化的-FLT3/STAT5下调,细胞周期停在 G1期和细胞凋亡。

In vitro(体外研究)
KW-2449, a multikinase inhibitor of FLT3, ABL, ABL-T315I, and Aurora kinase, is under investigation to treat leukemia patients. KW-2449 shows the potent growth inhibitory effects on leukemia cells with FLT3 mutations by inhibition of the FLT3 kinase, resulting in the down-regulation of phosphorylated-FLT3/STAT5, G1 arrest, and apoptosis. Oral administration of KW-2449 shows dose-dependent and significant tumor growth inhibition in FLT3-mutated xenograft model with minimum bone marrow suppression. In FLT3 wild-type human leukemia, KW-2449 induces the reduction of phosphorylated histone H3, G2/M arrest, and apoptosis. In Imatinib-resistant leukemia, KW-2449 contributes to release of the resistance by the simultaneous down-regulation of BCR/ABL and Aurora kinases. The inhibitory activity of KW-2449 is not affected by the presence of human plasma protein, such as α1-acid glycoprotein. KW-2449 has potent growth inhibitory activity against various types of leukemia by several mechanisms of action. KW-2449 has significant activity and warrants clinical study in leukemia patients with FLT3 mutations as well as Imatinib-resistant mutations. Phosphorylation levels of FLT3 and STAT5 are decreased by KW-2449 in a dose-dependent manner. In addition, it potently inhibits ABL-T315I, which is associated with IM resistance, with IC50 of 4 nM. On the other hand, KW-2449 has little effect on PDGFRβ, IGF-1R, EGFR, and various serine/threonine kinases even at a concentration of 1 μM. KW-2449 has the potent growth inhibitory activities against not only FLT3/ITD-expressing leukemia cells but also FLT3/KDM-activated and wild-type FLT3-overexpressing leukemia cells. In accordance with growth inhibitory effect, KW-2449 suppresses the phosphorylations of FLT3 (P-FLT3) and its downstream molecule phospho-STAT5 (P-STAT5) in MOLM-13 cells in a dose-dependent manner. Furthermore, KW-2449 increases the percentage of cells in the G1 phase of the cell cycle and reciprocally reduces the percentage of cells in the S phase, resulting in the increase of apoptotic cell population. KW-2449 can dephosphorylate constitutively active WT-FLT3 kinase but not inhibit the proliferation of leukemia cells if they are not mainly addicted to FLT3 the kinase. KW-2449 is rapidly absorbed and converted to a major metabolite M1.Preclinical studies reveal that KW-2449 is converted by monoamine oxidase-B (MAO-B) and aldehyde oxidase into its major metabolite M1.KW-2449 mediates cytotoxicity thru inhibition of FLT3/ITD.KW-2449 is a direct inhibitor of FLT3 and induces inhibition of its downstream target STAT5. KW2449 interacts synergistically with HDACIs to induce apoptosis in Ph+ CML cells in a time- and concentration-dependent manner. KW2449 synergistically enhances the lethality of vorinostat/SNDX275 in CML cells.KW-2449 regimens are active against additional IM-resistant Bcr/Abl+ leukemia cells. KW2449 moderately reduces phosphorylation of histone H3, an indicator of Aurora B activity, in nocodozole-treated K562 cells.
In vivo(体内研究)
In the MOLM-13 tumor xenograft model, oral administration of KW-2449 for 14 days shows a potent and significant antitumor effect in a dose-dependent manner.
三、背景
CAS号1000669-72-6
四、制备和贮存
保存方式Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.
五、产品特点
  • 品质保证:经过严格的质量控制,确保产品的高品质和稳定性。
  • 高纯度:纯度达到<p>>98%</p>。
六、注意事项
  • 本产品仅供科学研究使用,不可用于临床诊断或治疗。
  • 请在通风良好的环境下操作,佩戴适当的个人防护装备。
  • 如不慎接触皮肤或眼睛,请立即用大量清水冲洗并就医。
,KW 2449,KW2449

公司简介

爱必信是优宁维生物旗下自主品牌,是一家从事生物学试剂及耗材的高新技术企业。公司秉承“为生命科学创造便利!为客户创造价值!为员工创造幸福人生!”的发展理念,拥有专业的产品研发质检团队、市场营销团队及先进仓储物流等管理团队。荣获2021年度上海市“专精特新”企业称号。 主要经营产品有:生化试剂(常用生化试剂、生物学实验常用试剂、荧光染料、激动剂/抑制剂,植物提取物)、细胞生物学(细胞培养产品、血清、基质胶、添加剂、检测试剂盒)、免疫学产品、分子生物学产品、实验室仪器/耗材、产品定制和检测服务。 Absin还提供一些独有的特色产品:霍乱毒素B亚单位(CTB)、 鸡胚提取物(CEE)、 牛脑垂体提取物、 呼吸爆发试剂盒、 多色免疫组化试剂盒、 mRNA原料等在业界深受客户喜欢。 Absin秉承踏实,务实,求精和不断创新的精神为中国科学家提供优质产品,努力打造属于中国自己的生物试剂品牌,为广大科学家提供更全面更丰富更优质的产品。 爱科研,必信它(Absin)! Absin-生命科学百宝箱∑! 欢迎访问我们网站:www.absin.cn, 更多产品、更多便利,就在你身边!

成立日期 (16年)
注册资本 2500万
员工人数 100-500人
年营业额 ¥ 1000万-5000万
经营模式 工厂,试剂,定制,服务
主营行业 生化试剂,抗体,分子生物学,生物活性小分子

[4-[2-(1H-吲唑-3-基)乙烯基]苯基]-1-哌嗪基甲酮相关厂家报价 更多

  • KW-2449
  • KW-2449
  • 南京百鑫德诺生物科技有限公司
  • 2024-09-26
  • 询价
内容声明
拨打电话 立即询价